Official UK visa sponsor profile for BioNTech UK Limited in London, including current register status, route details, and public company data.
BioNTech UK Limited, registered in England and Wales with registration number 13041271, is an active limited company established on November 24, 2020. It operates from Suite 4, 7th Floor 50 Broadway, London, SW1H 0DB. The company’s industry classification according to the SIC code is 21200, categorized as “Pharmaceutical Preparation”. BioNTech UK Limited specializes in the manufacture of pharmaceutical preparations. Based on website information, the company’s primary focus lies in the development of mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, alongside vaccines against infectious diseases. While the company size is not explicitly stated on its website, BioNTech is a globally recognized pharmaceutical company. Considering its operations and research focus, it is reasonable to assume a significant operational scale, likely involving a substantial number of employees and considerable research and development investment. The company’s financial status indicates that accounts for the year ending December 31, 2024, are available. There are no recorded charges, and the company is not insolvent. BioNTech UK Limited holds a Skilled Worker visa, with a rating of Worker (A rating). The company’s operations are centered around research and development within the pharmaceutical sector.
Official UK visa sponsor profile for BioNTech UK Limited in London, including current register status, route details, and public company data.
BioNTech UK Limited, registered in England and Wales with registration number 13041271, is an active limited company established on November 24, 2020. It operates from Suite 4, 7th Floor 50 Broadway, London, SW1H 0DB. The company’s industry classification according to the SIC code is 21200, categorized as “Pharmaceutical Preparation”. BioNTech UK Limited specializes in the manufacture of pharmaceutical preparations. Based on website information, the company’s primary focus lies in the development of mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, alongside vaccines against infectious diseases. While the company size is not explicitly stated on its website, BioNTech is a globally recognized pharmaceutical company. Considering its operations and research focus, it is reasonable to assume a significant operational scale, likely involving a substantial number of employees and considerable research and development investment. The company’s financial status indicates that accounts for the year ending December 31, 2024, are available. There are no recorded charges, and the company is not insolvent. BioNTech UK Limited holds a Skilled Worker visa, with a rating of Worker (A rating). The company’s operations are centered around research and development within the pharmaceutical sector.
Yes, BioNTech UK Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
BioNTech UK Limited is classified under: Manufacture of pharmaceutical preparations, Research and experimental development on biotechnology.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, BioNTech UK Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
BioNTech UK Limited is classified under: Manufacture of pharmaceutical preparations, Research and experimental development on biotechnology.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.